Preisträger 2017
- Dr. med. Christian Scheer: Quality Improvement Initiative for Severe Sepsis and Septic Shock Reduces 90-Day Mortality: A 7.5-Year Observational Study . Crit Care Med. 2017 Feb;45(2):241-252
-
- Dr. med. Christian Scheer
Preisträger 2016
- SepNet-Studiengruppe: Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock. A Randomized Clinical Trial. JAMA Int Med. 2016 Sep 1;176(9):1266-76
-
- SepNet-Studiengruppe
Preisträger 2014
- PD Dr. med. Simon Schäfer, Essen: Hydrocortisone Fails to Abolish NF-kB1 Protein Nuclear Translocation in Deletion Allele Carriers of the NFKB1 Promoter Polymorphism (-94ins/delATTG) and Is Associated with Increased 30-Day Mortality in Septic Shock. American Journal of Respiratory and Critical Care Medicine, Vol. 187, 2013
-
- PD Dr. med. Simon Schäfer
-
Preisträger 2013
- PD Dr. med. Steffen Weber-Carstens, Berlin: Critical Illness Myopathy and GLUT4 – Significance of Insulin and Muscle Contraction. American Journal of Respiratory and Critical Care Medicine, Vol. 187, 2013
-
- PD Dr. med. Steffen Weber-Carstens
-
Preisträger 2012
- Dr. med. Martin Kolditz, Dresden: Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study . BMC Infectious Diseases 2012, 12:90.
-
- Dr. med. Martin Kolditz
-
Preisträger 2011
- PD Dr. med. Michael Adamzik, Essen: Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults . Critical Care 2010, 14(5):R178
-
- PD Dr. med. Michael Adamzik
-
Preisträger 2010
- Dr. Jörg C. Schefold, Berlin: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial . American Journal of Respiratory an Critical Care Medicine
- Dr. Christian Meisel, Berlin: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial . American Journal of Respiratory and Critical Care Medicine
-
- Dr. Jörg C. Schefold
-
- Dr. Christian Meisel
-
Preisträger 2008
- N. Rafat, Mannheim: Increased circulation endothelial progenitor cells in septic patients: Correlation with survival . Critical Care Medicine 2007; 35:1677-1684
-
- N. Rafat
-
Preisträger 2007
- Dr. med. J. C. Schefold, Berlin: A novel selevtive extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin-6, and complement-activating product 5a . Shock 2007
-
- Dr. Jörg C. Schefold
-
Preisträger 2006
- PD Dr. med. M. Westphal, Münster: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study . Critical Care Medicine 2006, Vol. 34, No. 9: 2287-2293.
-
- PD Dr. med. M. Westphal
-
Preisträger 2005
- Dr. M. Brückmann; Mannheim: Prognostic value of plasma N-terminal pro brain natriuretic peptide in patients with severe sepsis . Circulation, 2005;112: 527-534
-
- Dr. M. Brückmann
-
Preisträger 2004
- Dr. med. K. Mayer, Gießen: Parenteral Nutrition with Fish Oil Modulates Cytokine Response in Patients with Sepsis . Am J Respir Crit Care Med 2003;167:1321-1328.
-
- Dr. med. K. Mayer
-
Preisträger 2003
- Dr. med. D. Keh: Immunologic and Hemodynamic Effects of „Low-dose“ Hydrocortisone in Septic Shock: a Double-Blind, Randomized, Placebo-controlled, Crossover Study . Am J Respir Crit Care Med 2003;167(4):512-20
-
- Dr. med. D. Keh
-
Preisträger 2002
- Dr. med. M. Huber-Lang: Protective effects of anti-C5a peptide antibodies in experimental sepsis . FASEB J, 15 (2001)
- Dr. med. J. Zweigner: High concentrations of lipopolysaccharide-binding protein (LBP) in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes . Blood, 89 (2001)
-
- Dr. med. M. Huber-Lang
-
- Dr. med. J. Zweigner
-